Chidamide (also named Tucidinostat) is a histone deacetylase (HDAC) inhibitor that is used to treat various…
About Pirtobrutinib Pirtobrutinib is an inhibits B cell lymphocyte proliferation and survival by binding and inhibiting Bruton's tyrosine…
Golidocitinib (DZD4205) is currently the first and only Janus kinase 1 (JAK1) selective inhibitor being evaluated…
Zimberelimab is an anti-programmed cell death protein-1 (PD-1) monoclonal antibody being developed by Gloria Biosciences, Arcus…
About Penpulimab Penpulimab is an IgG1 monoclonal antibody that's designed to eliminate Fcγ receptor binding and…
About Pirtobrutinib Pirtobrutinib is an inhibits B cell lymphocyte proliferation and survival by binding and inhibiting Bruton's tyrosine…
TYVYT® (sintilimab injection) is a fully human IgG4 monoclonal antibody, which specifically binds to PD-1 expressed on…
About Cejemly® (Sugemalimab) The anti-PD-L1 monoclonal antibody sugemalimab was discovered by CStone using the OmniRat® transgenic animal…
About Tazemetostat Tazemetostat is a selective inhibitor of EZH2, administered orally.It is approved treatment for Follicular…
ABout Crizotinib Crizotinib is a prescription medicine used to treat people with non-small cell lung cancer…
Tevimbra (Tislelizumab-jsgr) sold under the brand name 百泽安 in china, is a humanized IgG4 anti–PD-1 monoclonal…
BRUKINSA (Zanubrutinib) sold under the brand name 百悦泽 in china, is a BTK Inhibitor used to…
Crizotinib is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that…
Selinexor is used along with dexamethasone to treat multiple myeloma (a type of cancer of the bone marrow)…
Acalabrutinib is used to treat people with mantle cell lymphoma (MCL; a fast-growing cancer that begins…
Ibrutinib is in a class of medications called kinase inhibitors. It works by blocking the action of…